A complete application in a minute
Tailored resume and cover letter, ready to send.
ARS Pharmaceuticals is seeking a Senior Vice President, Marketing & New Product Strategy to lead commercial strategy for neffy and the company’s portfolio. This executive will steer brand planning, patient and provider engagement, and strategic action across marketing, market access, and business development, ensuring alignment with regulatory and clinical teams.
The role requires a proven track record in strategic marketing leadership, portfolio management, and cross-functional collaboration to
ARS Pharmaceuticals is a fast‑growing, innovative company dedicated to transforming the treatment of severe allergic reactions with neffy®, the first and only FDA‑approved needle‑free epinephrine product. If you're motivated to make a meaningful impact, this is your opportunity to join a collaborative, entrepreneurial, and inclusive culture.
The Senior Vice President, Marketing & New Product Strategy is a senior commercial leader responsible for setting and delivering the commercial strategy for ARS Pharmaceuticals' current and future portfolio. Reporting to the Chief Commercial Officer, this role leads four areas critical to the company's growth: the U.S. marketing function for neffy®, New Product Planning for the pipeline, management of neffy® ex‑US supply partnerships, and Public Relations and Advocacy.
As the commercial lead for the company's development assets, the Senior Vice President, Marketing & New Product Strategy will lead coordination across functions to build the integrated project plan for each asset, ensure the asset strategy is sound and commercially differentiated, establish clear milestones, and hold the organization accountable for hitting timelines. This leadership extends to ARS Pharmaceuticals' internally developed assets as well as any assets the company may acquire or in‑license, beginning with the CSU asset and expanding as the portfolio grows.
The Senior Vice President, Marketing & New Product Strategy will be a strategic voice on the commercial and product leadership teams, shaping brand positioning, portfolio priorities, budget allocation, and contributing to business development decisions. The role partners closely with Sales, Market Access, Medical Affairs, Clinical Development, Regulatory, Commercial Operations, Finance, Legal, and Business Development, and is accountable for building and sustaining a high‑performing team and a culture of accountability, urgency, and excellence.
All activities will be conducted with the highest standards of integrity and in full compliance with Federal, State, and Local regulations and company policies.
Provides strategic direction and inspirational leadership to the marketing organization, accountable for the neffy® brand strategy and annual brand plan. Leads a core strategy centered on driving healthcare provider (HCP) behavior change, developing and executing HCP strategies, messaging, and programs that increase prescribing and adoption of neffy® across priority specialties and segments. Leads a precise, consumer strategy, deploying targeted, data‑driven campaigns that reach the highest‑value patient and caregiver audiences. Also responsible for complementary patient and caregiver programs. Leads the full marketing mix, including omnichannel and digital programs, by fully leveraging external agency partners and effectively partnering with the promotional review committee. Ensures brand plans are insight‑driven, enable competitive differentiation, and deliver an exceptional customer experience. Establishes clear brand performance tracking and diagnostics, applies advanced analytics to inform decisions, and rapidly develops action plans for course correction. Partners with Sales to ensure brand strategy translates into effective field execution, and with Market Access on pricing, contracting, and payer strategy.
Serves as the lead for integrated new product planning across the company's development assets, with initial focus on the CSU asset and expanding as the portfolio grows. Works in close partnership with the Chief Medical Officer, who leads clinical and development strategy, serving as the commercial counterpart to ensure the development program and the commercial strategy are built together and remain aligned from early planning through launch. Translate development decisions into commercial implications and brings market, payer, and competitive insight into development planning so that study design, endpoints, and label strategy reflect what will differentiate the asset in the market. Leads coordination across Clinical Development, Medical Affairs, Regulatory, CMC, Market Access, Commercial Operations, and Finance to develop the integrated project plan for each asset, ensuring the asset strategy is sound, milestones are established, and timelines are hit. Develops the target product profile, positioning, segmentation, launch archetype, and pre‑launch roadmap for each asset. Defines market opportunity, patient journey, treatment pathways, and payer dynamics, and identifies where the company can win. Develops commercial assessments that inform go/no‑go decisions and portfolio prioritization. Applies the same integrated leadership to assets the company may acquire or in‑license, partnering with Business Development on commercial evaluation and due diligence, and leading integration of acquired assets into